Immuron (IMRN) Depreciation & Amortization (CF) (2020 - 2023)
Immuron (IMRN) posted quarterly Depreciation & Amortization (CF) of $32523.8 for Q2 2023, up 70.62% year-over-year from $19062.0 in Q2 2022, and up 70.62% quarter-over-quarter from $19062.0 in Q2 2022.
Immuron (IMRN) Depreciation & Amortization (CF) (2020 - 2023) Analysis & Trends
Immuron's Depreciation & Amortization (CF) history runs 4 years deep, the most recent figure standing at $32523.8 for Q2 2023.
- In Q2 2023, Depreciation & Amortization (CF) rose 70.62% year-over-year to $32523.8; the TTM figure through Dec 2023 stood at $32523.8 (up 70.62% YoY), while the FY2023 annual figure was $32523.8, up 70.62% from the prior year.
- Depreciation & Amortization (CF) for Q2 2023 stood at $32523.8, up from $19062.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $33622.1 in Q2 2021, with the low at $19062.0 in Q2 2022.
- The 4-year median for Depreciation & Amortization (CF) is $30699.5 (2023), against an average of $28520.8.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) tumbled 43.31% in 2022, then surged 70.62% in 2023.
- Immuron's Depreciation & Amortization (CF) stood at $28875.2 in 2020, then increased by 16.44% to $33622.1 in 2021, then sank by 43.31% to $19062.0 in 2022, then soared by 70.62% to $32523.8 in 2023.
- Business Quant data shows IMRN's Depreciation & Amortization (CF) at $32523.8 in Q2 2023, $19062.0 in Q2 2022, and $33622.1 in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Immuron | 6.75 Mn | 6.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 32,523.76 |
| Jun 30, 2023 | 32,523.76 |
| Jun 30, 2022 | 19,062.05 |
| Jun 30, 2022 | 19,062.05 |
| Jun 30, 2021 | 33,622.15 |
| Jun 30, 2021 | 33,622.15 |
| Jun 30, 2020 | 28,875.21 |
| Jun 30, 2020 | 28,875.21 |